Skip to content
The Nexus
HEALTHMay 26 · 12:43 UTCTHE ATLANTICDaniel Engber

Welcome to the Injection Age

The article discusses the shift from pill-based to injection-based treatments in the U.S., highlighting the rise of GLP-1 drugs like Ozempic and Mounjaro for weight loss, increased use of Botox and IVF-related hormone injections, and the growth of 'needle-forward' wellness services. It notes the FDA approval of semaglutide in 2021 as a catalyst for the obesity medication trend, alongside cultural influences like Joe Rogan's promotion of peptides.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting